Interferon‐gamma contributes to disease progression in the <i>Ndufs4</i> (−/−) model of Leigh syndrome
Allison R. Hanaford(Johns Hopkins Medicine)
Cited by 14
Related Papers
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
|Translational Oncology|2019|74
Peripheral macrophages drive <scp>CNS</scp> disease in the <i>Ndufs4</i>(−/−) model of Leigh syndrome
|Brain Pathology|2023|23
Peripheral macrophages causally contribute to disease onset and progression in the <i>Ndufs4</i> (KO) model of Leigh syndrome
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1